A novel loop-structure-based bispecific CAR that targets CD19 and CD22 with enhanced therapeutic efficacy against B-cell malignancies.

ABSTRACT:

SUBMITTER: Zhao L 

PROVIDER: S-EPMC11891134 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature